Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagdish Agrawal, a promoter of Ishita Drugs & Industries Ltd, acquired 222 equity shares of Rs. 10 each on September 4, 2025, through the open market on BSE. This increased his individual holding from 1,29,133 shares (4.32%) to 1,29,355 shares (4.33%) of the company's paid-up equity capital. The total share capital remains unchanged at 2,990,300 shares of Rs. 10 each. The disclosure was filed under Regulation 29(2) of the SEBI Takeover Regulations, which applies to promoter share acquisitions.
The acquisition is extremely small (just 222 shares, 0.01% change) and is unlikely to have any material impact on the stock price or shareholder value, but reflects minor promoter buying activity which is generally viewed as a positive confidence signal.